Global Muscarinic Acetylcholine Receptor Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ918431
Publisher: Date of Publish:
No. of Pages: 128 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Executive Summary According to GRD Survey data, the global Muscarinic Acetylcholine Receptor market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027. This report studies the Muscarinic Acetylcholine Receptor market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Muscarinic Acetylcholine Receptor in these regions, from 2016 to 2027, covering North America (United States, Canada and Mexico) Europe (Germany, France, UK, Italy, Spain and Russia, etc.) Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.) Market Snapshot, By Product Type M1 M4 M5 Others Market Snapshot, By Application Attention Deficit Hyperactivity Disorder Psychiatric Disorders Alzheimer's Disease Chronic Obstructive Pulmonary Disease Memory Impairment Market Snapshot, By Region: North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australia Central & South America Brazil Argentina Colombia Middle East & Africa Iran South Africa Israel Turkey Saudi Arabia Main Market Players Analyzed in this report, including: Sumitomo Dainippon Pharma Co Ltd NeuroHealing Pharmaceuticals Inc Karuna Pharmaceuticals Inc Heptares Therapeutics Ltd AstraZeneca Plc Anavex Life Sciences Corp The study objectives of this report are: To study and analyze the global Muscarinic Acetylcholine Receptor market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027. To understand industry structure of Muscarinic Acetylcholine Receptor market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To identify the key global Muscarinic Acetylcholine Receptor manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Muscarinic Acetylcholine Receptor market with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Muscarinic Acetylcholine Receptor submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Muscarinic Acetylcholine Receptor are as follows: History Year: 2016-2020 Base Year: 2020 Estimated Year: 2021 Forecast Year 2021 to 2027 This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources. For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Considered in the study: Raw material vendors Distributors/traders/wholesalers/suppliers Regulatory authorities, including government agencies and NGO Commercial research & development (R&D) institutions Importers and exporters Government organizations, research organizations, and consulting firms Trade/Industrial associations End-use industries
Table of Contents 1 Market Definition & Scope 1.1 Definition & Scope 1.2 Muscarinic Acetylcholine Receptor Product Specifications 1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity) 1.4 Global Muscarinic Acetylcholine Receptor Market Performance and Outlook 2 Market Development Performance under COVID-19 2.1 Influencing Factors of Industry Development in the Next Five Years 2.1.1 Drivers 2.1.2 Restraints 2.1.3 Opportunities 2.2 Porter’s Five Forces Analysis 2.3 Comparison of Alternatives and Muscarinic Acetylcholine Receptor 3 Supply Chain and Manufacturing Cost Analysis 3.1 Supply Chain Analysis 3.2 Raw Materials and Key Suppliers Analysis 3.2.1 Raw Materials Introduction 3.2.1 Raw Materials Key Suppliers List 3.3 Muscarinic Acetylcholine Receptor Sales Channel and Distributors Analysis 3.3.1 Muscarinic Acetylcholine Receptor Sales Channel 3.3.2 Muscarinic Acetylcholine Receptor Distributors 3.4 Key Buying Industries/Consumers 3.4.1 Major Buyers in Attention Deficit Hyperactivity Disorder 3.4.2 Major Buyers in Psychiatric Disorders 3.5 Muscarinic Acetylcholine Receptor Manufacturing Cost Structure Analysis 4 Market Segment: by Type 4.1 Muscarinic Acetylcholine Receptor Type Introduction 4.1.1 M1 4.1.2 M4 4.1.3 M5 4.1.4 Others 4.2 Global Muscarinic Acetylcholine Receptor Sales by Type 2016-2021 4.3 Global Muscarinic Acetylcholine Receptor Revenue by Type 2016-2021 4.4 Global Muscarinic Acetylcholine Receptor Price by Type 2016-2021 5 Market Segment: by Application 5.1 Muscarinic Acetylcholine Receptor Type Introduction 5.1.1 Attention Deficit Hyperactivity Disorder 5.1.2 Psychiatric Disorders 5.1.3 Alzheimer's Disease 5.1.3 Chronic Obstructive Pulmonary Disease 5.1.4 Memory Impairment 5.2 Global Muscarinic Acetylcholine Receptor Sales by Application 2016-2021 5.3 Global Muscarinic Acetylcholine Receptor Revenue by Application 2016-2021 5.4 Global Muscarinic Acetylcholine Receptor Price by Application 2016-2021 6 Marke Segment: by Region 6.1 Global Muscarinic Acetylcholine Receptor Market by Region 6.1.1 Global Muscarinic Acetylcholine Receptor Sales by Regions 6.1.2 Global Muscarinic Acetylcholine Receptor Revenue by Regions 6.2 North America Muscarinic Acetylcholine Receptor Market 2016-2021 6.3 Europe Muscarinic Acetylcholine Receptor Market 2016-2021 6.4 Asia Pacific Muscarinic Acetylcholine Receptor Market 2016-2021 6.5 South America Muscarinic Acetylcholine Receptor Market 2016-2021 6.6 Middle East and Africa Muscarinic Acetylcholine Receptor Market 2016-2021 7 North America 7.1 North America Muscarinic Acetylcholine Receptor Market by Country 2016-2021 7.1.1 North America Muscarinic Acetylcholine Receptor Sales by Country 7.1.2 North America Muscarinic Acetylcholine Receptor Revenue by Country 7.2 United States 7.3 Canada 7.4 Mexico 8 Europe 8.1 Europe Muscarinic Acetylcholine Receptor Market by Country 2016-2021 8.1.1 Europe Muscarinic Acetylcholine Receptor Sales by Country 8.1.2 Europe Muscarinic Acetylcholine Receptor Revenue by Country 8.2 Germany 8.3 France 8.4 UK 8.5 Italy 8.6 Russia 8.7 Spain 9 Asia Pacific 9.1 Asia Pacific Muscarinic Acetylcholine Receptor Market by Country 2016-2021 9.1.1 Asia Pacific Muscarinic Acetylcholine Receptor Sales by Country 9.1.2 Asia Pacific Muscarinic Acetylcholine Receptor Revenue by Country 9.2 China 9.3 Japan 9.4 Korea 9.5 Southeast Asia 9.6 India 9.7 Australia 10 South America 10.1 South America Muscarinic Acetylcholine Receptor Market by Country 2016-2021 10.1.1 South America Muscarinic Acetylcholine Receptor Sales by Country 10.1.2 South America Muscarinic Acetylcholine Receptor Revenue by Country 10.2 Brazil 10.3 Argentina 10.4 Colombia 11 Middle East and Africa 11.1 Middle East and Africa Muscarinic Acetylcholine Receptor Market by Country 2016-2021 11.1.1 Middle East and Africa Muscarinic Acetylcholine Receptor Sales by Country 11.1.2 Middle East and Africa Muscarinic Acetylcholine Receptor Revenue by Country 11.2 Turkey 11.3 Saudi Arabia 11.4 South Africa 12 Key Participants Company Information 12.1 Sumitomo Dainippon Pharma Co Ltd 12.1.1 Sumitomo Dainippon Pharma Co Ltd Company Information 12.1.2 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Product Portfolio, Specification and Application 12.1.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Sales, Price, Revenue and Gross Margin (2019-2021) 12.1.4 Sumitomo Dainippon Pharma Co Ltd Key Development 12.2 NeuroHealing Pharmaceuticals Inc 12.2.1 NeuroHealing Pharmaceuticals Inc Company Information 12.2.2 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product Portfolio, Specification and Application 12.2.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Revenue and Gross Margin (2019-2021) 12.2.4 NeuroHealing Pharmaceuticals Inc Key Development 12.3 Karuna Pharmaceuticals Inc 12.3.1 Karuna Pharmaceuticals Inc Company Information 12.3.2 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product Portfolio, Specification and Application 12.3.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Revenue and Gross Margin (2019-2021) 12.3.4 Karuna Pharmaceuticals Inc Key Development 12.4 Heptares Therapeutics Ltd 12.4.1 Heptares Therapeutics Ltd Company Information 12.4.2 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Product Portfolio, Specification and Application 12.4.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Sales, Price, Revenue and Gross Margin (2019-2021) 12.4.4 Heptares Therapeutics Ltd Key Development 12.5 AstraZeneca Plc 12.5.1 AstraZeneca Plc Company Information 12.5.2 AstraZeneca Plc Muscarinic Acetylcholine Receptor Product Portfolio, Specification and Application 12.5.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor Sales, Price, Revenue and Gross Margin (2019-2021) 12.5.4 AstraZeneca Plc Key Development 12.6 Anavex Life Sciences Corp 12.6.1 Anavex Life Sciences Corp Company Information 12.6.2 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Product Portfolio, Specification and Application 12.6.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Sales, Price, Revenue and Gross Margin (2019-2021) 12.6.4 Anavex Life Sciences Corp Key Development 13 Global Muscarinic Acetylcholine Receptor Market Forecast by Region by Type and by Application 13.1 Global Muscarinic Acetylcholine Receptor Sales, Revenue Forecast 2022-2027 13.2 Global Muscarinic Acetylcholine Receptor Forecast by Regions 13.2.1 Global Muscarinic Acetylcholine Receptor Sales Forecast by Region 2022-2027 13.2.2 Global Muscarinic Acetylcholine Receptor Revenue Forecast by Region 2022-2027 13.3 Global Muscarinic Acetylcholine Receptor Forecast by Type 13.3.1 Global Muscarinic Acetylcholine Receptor Sales Forecast by Type 2022-2027 13.3.2 Global Muscarinic Acetylcholine Receptor Revenue Forecast by Type 2022-2027 13.3.3 Global Muscarinic Acetylcholine Receptor Price Forecast by Type 2022-2027 13.4 Global Muscarinic Acetylcholine Receptor Forecast by Application 13.4.1 Global Muscarinic Acetylcholine Receptor Sales Forecast by Application 2022-2027 13.4.2 Global Muscarinic Acetylcholine Receptor Revenue Forecast by Application 2022-2027 13.4.3 Global Muscarinic Acetylcholine Receptor Price Forecast by Application 2022-2027 14 Analyst Views and Conclusions 15 Methodology and Data Source 15.1 Methodology 15.2 Research Data Source 15.2.1 Secondary Data 15.2.2 Primary Data 15.2.3 Market Size Estimation 15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com